VANGUARD GROUP INC - DIFFUSION PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748404. A total of 12 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$221,215
-26.7%
66,232
-9.0%
0.00%–
Q1 2023$301,967
-17.9%
72,7630.0%0.00%–
Q4 2022$367,984
-5.4%
72,763
+0.1%
0.00%–
Q3 2022$389,000
-27.2%
72,721
-9.1%
0.00%–
Q2 2022$534,000–79,970–0.00%–
 Download
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 16,565$54,9960.00%
Renaissance Technologies 40,309$1350.00%
VANGUARD GROUP INC 66,232$221,2150.00%
UBS Group AG 60$2000.00%
OSAIC HOLDINGS, INC. 594$1,9830.00%
WELLS FARGO & COMPANY/MN 15$500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,123$56,8480.00%
MORGAN STANLEY 548$1,8300.00%
BlackRock Inc. 32,852$109,7260.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders